Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

SB-228357

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
SB-228357
Identifiers
  • N-(3-fluoro-5-pyridin-3-ylphenyl)-5-methoxy-6-(trifluoromethyl)-2,3-dihydroindole-1-carboxamide
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC22H17F4N3O2
Molar mass431.391 g·mol−1
3D model (JSmol)
  • COC1=C(C=C2C(=C1)CCN2C(=O)NC3=CC(=CC(=C3)C4=CN=CC=C4)F)C(F)(F)F
  • InChI=1S/C22H17F4N3O2/c1-31-20-9-13-4-6-29(19(13)11-18(20)22(24,25)26)21(30)28-17-8-15(7-16(23)10-17)14-3-2-5-27-12-14/h2-3,5,7-12H,4,6H2,1H3,(H,28,30)
  • Key:RRJLJKRFFRZRAF-UHFFFAOYSA-N

SB-228357 is adrug which acts as aselectiveantagonist of theserotonin5-HT2B and5-HT2Creceptors.[1][2]

It hasantidepressant andanxiolytic effects inanimal models[1][2] and inhibits 5-HT2B mediatedproliferation ofcardiacfibroblasts.[3] It has also been found to reversemeta-chlorophenylpiperazine (mCPP)-inducedhypolocomotion[2] and to attenuatehaloperidol-inducedcatalepsy.[1]

The drug was under development byGlaxoSmithKline for the treatment ofmajor depressive disorder andanxiety disorders.[4] It reached thepreclinical research phase of development.[4] However, development of the drug was discontinued.[4]

See also

[edit]

References

[edit]
  1. ^abcReavill C, Kettle A, Holland V, Riley G, Blackburn TP (February 1999)."Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist".Br J Pharmacol.126 (3):572–574.doi:10.1038/sj.bjp.0702350.PMC 1565856.PMID 10188965.
  2. ^abcBromidge SM, Dabbs S, Davies DT, Davies S, Duckworth DM, Forbes IT, et al. (March 2000). "Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent".Journal of Medicinal Chemistry.43 (6):1123–34.doi:10.1021/jm990388c.PMID 10737744.
  3. ^Hutcheson JD, Ryzhova LM, Setola V, Merryman WD (November 2012)."5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation".Journal of Molecular and Cellular Cardiology.53 (5):707–14.doi:10.1016/j.yjmcc.2012.08.012.PMC 3472096.PMID 22940605.
  4. ^abc"SB 228357".AdisInsight. 18 January 2008. Retrieved14 January 2025.
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Stub icon

Thispharmacology-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=SB-228357&oldid=1269296832"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp